表紙
市場調查報告書

醫藥品新興國家市場

Pharmerging

出版商 Global Industry Analysts, Inc. 商品編碼 893767
出版日期 內容資訊 英文 118 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品新興國家市場 Pharmerging
出版日期: 2019年07月01日內容資訊: 英文 118 Pages
簡介

本報告提供醫藥品新興國家趨勢調查,市場定義和概要,主要趨勢、市場成長的各種影響因素分析,企業及企業間的配合措施,競爭環境與市場佔有率,世界及各地區、國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球企業佔有率
      • 企業佔有率方案:成果、預測
    • 企業佔有率成果、預測:各產品
      • 醫療保健產品
      • 醫藥品
  • 主要企業
  • 市場趨勢、成長推動因素
  • 全球市場的展望

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他
  • 亞太地區
  • 其他地區

第4章 競爭企業

  • ABBOTT LABORATORIES
  • ABBVIE
  • ALEXION PHARMACEUTICALS
  • ALLERGAN PLC
  • ASPEN PHARMACARE HOLDINGS
  • Astellas Pharma Inc.
  • ASTRAZENECA PLC
  • BAXTER INTERNATIONAL
  • BAYER AG
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRISTOL-MYERS SQUIBB COMPANY
  • CSL BEHRING
  • CELGENE CORPORATION
  • 第一三共
  • EISAI CO., LTD.
  • ELI LILLY AND COMPANY
  • ENDO INTERNATIONAL PLC
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • GRIFOLS SA
  • H. LUNDBECK A/S
  • HOSPIRA
  • JOHNSON & JOHNSON
  • 田邊三菱製藥
  • MYLAN PHARMACEUTICAL PVT.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • 大塚製藥
  • PFIZER
  • STADA ARZNEIMITTEL AG
  • SANOFI SA
  • SHIRE PLC
  • SUN PHARMACEUTICAL INDUSTRIES
  • 武田藥品工業
  • TEVA PHARMACEUTICAL INDUSTRIES
  • UCB SA
  • Kyowa Hakko Kirin

第5章 調查資料

目錄
Product Code: MCP16682

Pharmerging market worldwide is projected to grow by US$833 Thousand, guided by a compounded growth of 11.4%. Staying on top of trends is essential for decision makers to leverage this emerging opportunity. The report addresses this very need and provides the latest scoop on all major market segments. Pharmaceutical, one of the segments analyzed and sized in this study, displays the potential to grow at over 9.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$933.8 Thousand by the year 2025, Pharmaceutical will bring in healthy gains adding significant momentum to global growth.

While global megatrends sweeping through the market influence the primary direction of growth, regional markets are swayed by more granular locally unique business drivers. Representing the developed world, the United States will maintain a 13.8% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$68.8 Thousand to the region's size and clout in the next 5 to 6 years. Over US$74.5 Thousand worth of projected demand in the region will come from other emerging Eastern European markets. In Japan, Pharmaceutical will reach a market size of US$65.5 Thousand by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11% over the next couple of years and add approximately US$141.9 Thousand in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others, Abbott Laboratories (USA); AbbVie, Inc. (USA); Alexion Pharmaceuticals, Inc. (USA); Allergan PLC (Ireland); Amgen, Inc. (USA); Aspen Pharmacare Holdings Ltd. (South Africa); Astellas Pharma, Inc. (Japan); AstraZeneca PLC (United Kingdom); Baxter International, Inc. (USA); Bayer AG (Germany); Biogen, Inc. (USA); Boehringer Ingelheim International GmbH (Germany); Bristol-Myers Squibb Company (USA); Celgene Corporation (USA); CSL Behring (USA); Daiichi Sankyo Co., Ltd. (Japan); Eisai Co., Ltd. (Japan); Eli Lilly and Company (USA); Endo International PLC (Ireland); F. Hoffmann-La Roche AG (Switzerland); GlaxoSmithKline PLC (United Kingdom); Grifols SA (Spain); H. Lundbeck A/S (Denmark); Hospira, Inc. (USA); Johnson & Johnson (USA); Kyowa Hakko Kirin Co., Ltd. (Japan); Mallinckrodt Pharmaceuticals (USA); Mitsubishi Tanabe Pharma Corporation (Japan); Mylan Pharmaceutical Pvt. Ltd. (India); Novartis AG (Switzerland); Novo Nordisk A/S (Denmark); Otsuka Pharmaceutical Co., Ltd. (Japan); Pfizer, Inc. (USA); Sanofi SA (France); Shire PLC (Ireland); Stada Arzneimittel AG (Germany); Sun Pharmaceutical Industries Ltd. (India); Takeda Pharmaceutical Co., Ltd. (Japan); Teva Pharmaceutical Industries Ltd. (Israel); UCB SA (Belgium)

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
    • Pharmerging Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
  • Global Competitor Market Shares by Segment
    • Healthcare (Product) Global Competitor Market Share Positioning for 2019 & 2025
    • Pharmaceutical (Product) Market Share Breakdown of Key Players: 2019 & 2025

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Pharmerging Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Pharmerging Market Share Shift across Key Geographies Worldwide: 2019 VS 2025
  • TABLE 3: Healthcare (Product) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 4: Healthcare (Product) Market Sales Breakdown by Region/Country in Percentage: 2019 VS 2025
  • TABLE 5: Pharmaceutical (Product) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 6: Pharmaceutical (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

  • Market Facts & Figures
    • US Pharmerging Market Share (in %) by Company: 2019 & 2025
    • Healthcare (Product) Market Share Analysis (in %) of Leading Players in the US for 2019 & 2025
    • Pharmaceutical (Product) Competitor Revenue Share (in %) in the US: 2019 & 2025
  • TABLE 7: United States Pharmerging Market Estimates and Projections in US$ Million by Product: 2018 to 2025
  • TABLE 8: United States Pharmerging Market Share Breakdown by Product: 2019 VS 2025

CANADA

  • TABLE 9: Canadian Pharmerging Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
  • TABLE 10: Pharmerging Market in Canada: Percentage Share Breakdown of Sales by Product for 2019 and 2025

JAPAN

  • TABLE 11: Japanese Market for Pharmerging: Annual Sales Estimates and Projections in US$ Million by Product for the period 2018-2025
  • TABLE 12: Japanese Pharmerging Market Share Analysis by Product: 2019 VS 2025

CHINA

  • TABLE 13: Chinese Pharmerging Market Growth Prospects in US$ Million by Product for the Period 2018-2025
  • TABLE 14: Chinese Pharmerging Market by Product: Percentage Breakdown of Sales for 2019 and 2025

EUROPE

  • Market Facts & Figures
  • European Pharmerging Market: Competitor Market Share Scenario (in %) for 2019 & 2025
  • Healthcare (Product) Market Share (in %) by Company in Europe: 2019 & 2025
  • Pharmaceutical (Product) Market Share (in %) of Major Players in Europe: 2019 & 2025
  • TABLE 15: European Pharmerging Market Demand Scenario in US$ Million by Region/Country: 2018-2025
  • TABLE 16: European Pharmerging Market Share Shift by Region/Country: 2019 VS 2025
  • TABLE 17: European Pharmerging Market Estimates and Forecasts in US$ Million by Product: 2018-2025
  • TABLE 18: European Pharmerging Market Share Breakdown by Product: 2019 VS 2025

FRANCE

  • TABLE 19: Pharmerging Market in France by Product: Estimates and Projections in US$ Million for the Period 2018-2025
  • TABLE 20: French Pharmerging Market Share Analysis by Product: 2019 VS 2025

GERMANY

  • TABLE 21: Pharmerging Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2018-2025
  • TABLE 22: German Pharmerging Market Share Breakdown by Product: 2019 VS 2025

ITALY

  • TABLE 23: Italian Pharmerging Market Growth Prospects in US$ Million by Product for the Period 2018-2025
  • TABLE 24: Italian Pharmerging Market by Product: Percentage Breakdown of Sales for 2019 and 2025

UNITED KINGDOM

  • TABLE 25: United Kingdom Market for Pharmerging: Annual Sales Estimates and Projections in US$ Million by Product for the period 2018-2025
  • TABLE 26: United Kingdom Pharmerging Market Share Analysis by Product: 2019 VS 2025

REST OF EUROPE

  • TABLE 27: Rest of Europe Pharmerging Market Estimates and Forecasts in US$ Million by Product: 2018-2025
  • TABLE 28: Rest of Europe Pharmerging Market Share Breakdown by Product: 2019 VS 2025

ASIA-PACIFIC

  • TABLE 29: Pharmerging Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2018-2025
  • TABLE 30: Asia-Pacific Pharmerging Market Share Analysis by Product: 2019 VS 2025

REST OF WORLD

  • TABLE 31: Rest of World Pharmerging Market Estimates and Forecasts in US$ Million by Product: 2018 to 2025
  • TABLE 32: Pharmerging Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2019 and 2025

IV. COMPETITION

  • ABBOTT LABORATORIES
  • ABBVIE
  • ALEXION PHARMACEUTICALS
  • ALLERGAN PLC
  • ASPEN PHARMACARE HOLDINGS
  • ASTELLAS PHARMA
  • ASTRAZENECA PLC
  • BAXTER INTERNATIONAL
  • BAYER AG
  • BOEHRINGER INGELHEIM INTERNATIONAL GMBH
  • BRISTOL-MYERS SQUIBB COMPANY
  • CSL BEHRING
  • CELGENE CORPORATION
  • DAIICHI SANKYO
  • EISAI CO., LTD.
  • ELI LILLY AND COMPANY
  • ENDO INTERNATIONAL PLC
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • GRIFOLS SA
  • H. LUNDBECK A/S
  • HOSPIRA
  • JOHNSON & JOHNSON
  • MITSUBISHI TANABE PHARMA CORPORATION
  • MYLAN PHARMACEUTICAL PVT.
  • NOVARTIS AG
  • NOVO NORDISK A/S
  • OTSUKA PHARMACEUTICAL
  • PFIZER
  • STADA ARZNEIMITTEL AG
  • SANOFI SA
  • SHIRE PLC
  • SUN PHARMACEUTICAL INDUSTRIES
  • TAKEDA PHARMACEUTICAL COMPANY LIMITED
  • TEVA PHARMACEUTICAL INDUSTRIES
  • UCB SA
  • KYOWA HAKKO KIRIN

V. CURATED RESEARCH

Back to Top